These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 36599979)

  • 1. Cas12a2 elicits abortive infection through RNA-triggered destruction of dsDNA.
    Dmytrenko O; Neumann GC; Hallmark T; Keiser DJ; Crowley VM; Vialetto E; Mougiakos I; Wandera KG; Domgaard H; Weber J; Gaudin T; Metcalf J; Gray BN; Begemann MB; Jackson RN; Beisel CL
    Nature; 2023 Jan; 613(7944):588-594. PubMed ID: 36599979
    [TBL] [Abstract][Full Text] [Related]  

  • 2. RNA targeting unleashes indiscriminate nuclease activity of CRISPR-Cas12a2.
    Bravo JPK; Hallmark T; Naegle B; Beisel CL; Jackson RN; Taylor DW
    Nature; 2023 Jan; 613(7944):582-587. PubMed ID: 36599980
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CRISPR-Cas12a targeting of ssDNA plays no detectable role in immunity.
    Marino ND; Pinilla-Redondo R; Bondy-Denomy J
    Nucleic Acids Res; 2022 Jun; 50(11):6414-6422. PubMed ID: 35670674
    [TBL] [Abstract][Full Text] [Related]  

  • 4. TracrRNA reprogramming enables direct PAM-independent detection of RNA with diverse DNA-targeting Cas12 nucleases.
    Jiao C; Peeck NL; Yu J; Ghaem Maghami M; Kono S; Collias D; Martinez Diaz SL; Larose R; Beisel CL
    Nat Commun; 2024 Jul; 15(1):5909. PubMed ID: 39003282
    [TBL] [Abstract][Full Text] [Related]  

  • 5. DNA targeting by subtype I-D CRISPR-Cas shows type I and type III features.
    Lin J; Fuglsang A; Kjeldsen AL; Sun K; Bhoobalan-Chitty Y; Peng X
    Nucleic Acids Res; 2020 Oct; 48(18):10470-10478. PubMed ID: 32960267
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The miniature CRISPR-Cas12m effector binds DNA to block transcription.
    Wu WY; Mohanraju P; Liao C; Adiego-Pérez B; Creutzburg SCA; Makarova KS; Keessen K; Lindeboom TA; Khan TS; Prinsen S; Joosten R; Yan WX; Migur A; Laffeber C; Scott DA; Lebbink JHG; Koonin EV; Beisel CL; van der Oost J
    Mol Cell; 2022 Dec; 82(23):4487-4502.e7. PubMed ID: 36427491
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synergistic effect of split DNA activators of Cas12a with exon-unwinding and induced targeting effect.
    Huang S; Lou Y; Zheng L
    Nucleic Acids Res; 2024 Oct; 52(18):11148-11157. PubMed ID: 39258555
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dynamic mechanisms of CRISPR interference by Escherichia coli CRISPR-Cas3.
    Yoshimi K; Takeshita K; Kodera N; Shibumura S; Yamauchi Y; Omatsu M; Umeda K; Kunihiro Y; Yamamoto M; Mashimo T
    Nat Commun; 2022 Aug; 13(1):4917. PubMed ID: 36042215
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Determinants of CRISPR Cas12a nuclease activation by DNA and RNA targets.
    Nalefski EA; Kooistra RM; Parikh I; Hedley S; Rajaraman K; Madan D
    Nucleic Acids Res; 2024 May; 52(8):4502-4522. PubMed ID: 38477377
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular insights into DNA interference by CRISPR-associated nuclease-helicase Cas3.
    Gong B; Shin M; Sun J; Jung CH; Bolt EL; van der Oost J; Kim JS
    Proc Natl Acad Sci U S A; 2014 Nov; 111(46):16359-64. PubMed ID: 25368186
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CRISPR-Cas12a target binding unleashes indiscriminate single-stranded DNase activity.
    Chen JS; Ma E; Harrington LB; Da Costa M; Tian X; Palefsky JM; Doudna JA
    Science; 2018 Apr; 360(6387):436-439. PubMed ID: 29449511
    [TBL] [Abstract][Full Text] [Related]  

  • 12. RNA activation-independent DNA targeting of the Type III CRISPR-Cas system by a Csm complex.
    Park KH; An Y; Jung TY; Baek IY; Noh H; Ahn WC; Hebert H; Song JJ; Kim JH; Oh BH; Woo EJ
    EMBO Rep; 2017 May; 18(5):826-840. PubMed ID: 28364023
    [TBL] [Abstract][Full Text] [Related]  

  • 13. trans Single-Stranded DNA Cleavage via CRISPR/Cas14a1 Activated by Target RNA without Destruction.
    Wei Y; Yang Z; Zong C; Wang B; Ge X; Tan X; Liu X; Tao Z; Wang P; Ma C; Wan Y; Li J
    Angew Chem Int Ed Engl; 2021 Nov; 60(45):24241-24247. PubMed ID: 34553468
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Structural insights into target DNA recognition and cleavage by the CRISPR-Cas12c1 system.
    Zhang B; Lin J; Perčulija V; Li Y; Lu Q; Chen J; Ouyang S
    Nucleic Acids Res; 2022 Nov; 50(20):11820-11833. PubMed ID: 36321657
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Type III CRISPR-Cas: beyond the Cas10 effector complex.
    Stella G; Marraffini L
    Trends Biochem Sci; 2024 Jan; 49(1):28-37. PubMed ID: 37949766
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Conformational Activation Promotes CRISPR-Cas12a Catalysis and Resetting of the Endonuclease Activity.
    Stella S; Mesa P; Thomsen J; Paul B; Alcón P; Jensen SB; Saligram B; Moses ME; Hatzakis NS; Montoya G
    Cell; 2018 Dec; 175(7):1856-1871.e21. PubMed ID: 30503205
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A new family of CRISPR-type V nucleases with C-rich PAM recognition.
    Urbaitis T; Gasiunas G; Young JK; Hou Z; Paulraj S; Godliauskaite E; Juskeviciene MM; Stitilyte M; Jasnauskaite M; Mabuchi M; Robb GB; Siksnys V
    EMBO Rep; 2022 Dec; 23(12):e55481. PubMed ID: 36268581
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cas13-induced cellular dormancy prevents the rise of CRISPR-resistant bacteriophage.
    Meeske AJ; Nakandakari-Higa S; Marraffini LA
    Nature; 2019 Jun; 570(7760):241-245. PubMed ID: 31142834
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Single-Stranded DNA Cleavage by Divergent CRISPR-Cas9 Enzymes.
    Ma E; Harrington LB; O'Connell MR; Zhou K; Doudna JA
    Mol Cell; 2015 Nov; 60(3):398-407. PubMed ID: 26545076
    [TBL] [Abstract][Full Text] [Related]  

  • 20. PAM recognition by miniature CRISPR-Cas12f nucleases triggers programmable double-stranded DNA target cleavage.
    Karvelis T; Bigelyte G; Young JK; Hou Z; Zedaveinyte R; Budre K; Paulraj S; Djukanovic V; Gasior S; Silanskas A; Venclovas Č; Siksnys V
    Nucleic Acids Res; 2020 May; 48(9):5016-5023. PubMed ID: 32246713
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.